Rifamycin Sodium

CHEMBL2105680 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

719.7 g/mol

LogP

—

Phase

4

Rifamycin sodium is the sodium salt form of rifamycin, an ansamycin antibiotic that inhibits bacterial RNA polymerase; the sodium salt formulation improves water solubility for parenteral and oral administration. See rifamycin for complete pharmacological details.

Masse moléculaire

719,7000 g/mol

TPSA

204,00 Å²

Aires thérapeutiques

Parkinson's Disease Infectious Disease Tuberculosis Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c([O-])c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C.[Na+]

InChI

InChI=1S/C37H47NO12.Na/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41;/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46);/q;+1/p-1/b11-10+,14-13+,17-12-;/t16-,18+,19+,20+,25-,29-,30+,33+,37-;/m0./s1

Molecular Formula

C37H46NNaO12

HBD / HBA

5 / 12

Liaisons Rotatives

3

Atomes Lourds

51

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Rifamycin sodium is the sodium salt form of rifamycin, an ansamycin antibiotic that inhibits bacterial RNA polymerase; the sodium salt formulation improves water solubility for parenteral and oral administration. See rifamycin for complete pharmacological details.

Yes, Rifamycin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105680. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23702994. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Rifamycin Sodium sur PillFYI

Structure

Données Clés

Formule: C37H46NNaO12

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.